응급 간이식을 받은 전격성 A형간염 환자의 임상 양상: 다른 원인에 의한 급성 간부전 환자와의 비교
Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: According to recent prevalence of hepatitis A virus (HAV) infection, acute liver failure (ALF) due to HAV infection is observed frequently in parallel. The aim of this study was to elucidate the clinical, laboratory, and pathologic features of patients who have undergone emergency liver transplantation (LT) due to fulminant HAV infection. Methods: Clinical, laboratory, and pathologic data of 11 transplant recipients with anti-HAV IgM-positive ALF between December 2007 and May 2009 were analyzed, and compared with data of 10 recipients who underwent LT for the management of ALF due to other causes. Results: The median age of the patients with HAV-related ALF was 34 years (range: 15-43 years). The levels of hemoglobin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine were higher and the level of bilirubin was lower in the HAV-related ALF group than in the other group (P=0.005, 0.001, 0.001, 0.010, and 0.003, respectively). The time from the onset of initial symptoms to the development of encephalopathy was shorter in the HAV-related ALF group than in the other group (median 5 days, range: 4-13 days; P<0.001). In patients with HAV-related ALF, laboratory findings and clinical prognostic parameters including the Acute Liver Failure Study Group prognostic index, King’s College criteria, and model for endstage liver disease (MELD) and Child-Pugh scores were not associated with the grade of hepatic encephalopathy or time of progression to encephalopathy. Conclusions: The results of this study indicate that the clinical condition of patients with HAV-related ALF requiring emergency LT aggravates rapidly. Prognostic parameters are not sufficient for discriminating transplant candidates in patients with fulminant hepatitis A
Abstract
Background/Aims: According to recent prevalence of hepatitis A virus (HAV) infection, acute liver failure (ALF) due to HAV infection is observed frequently in parallel. The aim of this study was to elucidate the clinical, laboratory, and pathologic features of patients who have undergone emergency liver transplantation (LT) due to fulminant HAV infection. Methods: Clinical, laboratory, and pathologic data of 11 transplant recipients with anti-HAV IgM-positive ALF between December 2007 and May 2009 were analyzed, and compared with data of 10 recipients who underwent LT for the management of ALF due to other causes. Results: The median age of the patients with HAV-related ALF was 34 years (range: 15-43 years). The levels of hemoglobin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine were higher and the level of bilirubin was lower in the HAV-related ALF group than in the other group (P=0.005, 0.001, 0.001, 0.010, and 0.003, respectively). The time from the onset of initial symptoms to the development of encephalopathy was shorter in the HAV-related ALF group than in the other group (median 5 days, range: 4-13 days; P<0.001). In patients with HAV-related ALF, laboratory findings and clinical prognostic parameters including the Acute Liver Failure Study Group prognostic index, King’s College criteria, and model for endstage liver disease (MELD) and Child-Pugh scores were not associated with the grade of hepatic encephalopathy or time of progression to encephalopathy. Conclusions: The results of this study indicate that the clinical condition of patients with HAV-related ALF requiring emergency LT aggravates rapidly. Prognostic parameters are not sufficient for discriminating transplant candidates in patients with fulminant hepatitis A
참고문헌 (17)
- Rezende G, "Viral and clinical factors associated with the fulminant course of hepatitis A infection", Hepatology, 38, pp.613~618 (2003)
- Lee WM, "Acute liver failure: Summary of a workshop", Hepatology, 47, pp.1401~1415 (2008)
- Pugh RN, "Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
- Kamath PS, "The model for end-stage liver disease (MELD)", Hepatology, 45, pp.797~805 (2007)
- O’Grady JG, "Early indicators of prognosis in fulminant hepatic failure", Gastroenterology, 97, pp.439~445 (1989)
- Taylor RM, "Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes", Hepatology, 44, pp.1589~1597 (2006)
- Conn HO, "Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial", Gastroenterology, 72, pp.573~583 (1977)
- Trey C, "The management of fulminant hepatic failure", Prog Liver Dis, 3, pp.282~298 (1970)
- Bellomo R, "Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group", Crit Care, 8, pp.204~212 (2004)
- Kyrlagkitsis I, "Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center", Hepatogastroenterology, 49, pp.524~528 (2002)
- 김좌민, "전격성 A형간염의 임상양상 및 자발생존에 관한 예측인자", The Korean Journal of Hepatology, 14(4), pp.474~482 (2008), 대한간학회
- Ware AJ, "Cerebral edema: a major complication of massive hepatic necrosis", Gastroenterology, 61, pp.877~884 (1971)
- O’Brien CJ, "Neurological sequelae in patients recovered from fulminant hepatic failure", Gut, 28, pp.93~95 (1987)
- Munoz SJ, "Difficult management problems in fulminant hepatic failure", Semin Liver Dis, 13, pp.395~413 (1993)
- Ostapowicz G, "Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States", Ann Intern Med, 137, pp.947~954 (2002)
- Daniels D, "Surveillance for acute viral hepatitis-United States, 2007", MMWR Surveill Summ, 58, pp.1~27 (2007)